Despite prior evidence linking APOL1 G1/G2 variants to kidney disease and their strong pQTL effects on plasma APOL1 observed in our study, we did not detect a significant association between these variants and ESRD risk in the UK Biobank. Here, APOL1 is linked to kidney disorder.